Last reviewed · How we verify
NCT07310147
Empower Your Mind to Embrace Your Life: an Online ACT Intervention for Young-Onset Parkinson's Disease
NA trial testing Empower your mind to embrace your life in Parkinson's Disease (PD) in 20 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | University of Coimbra |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 April 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Empower your mind to embrace your life
Conditions studied
- Parkinson's Disease (PD) — all drugs for Parkinson's Disease (PD) →
Sponsor
University of Coimbra
Who can join
Adults 21 to 65, any sex, with Parkinson's Disease (PD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parkinson's disease (PD) has a substantial impact on daily life and significantly affects functioning, mental health and quality of life. Although considered a disease of the elderly, an early diagnosis is also common. Non-pharmacological interventions have been increasingly recommended for PD, including psychotherapy, with emerging evidence suggesting that Acceptance and Commitment Therapy (ACT) may be suitable to support individuals living with PD. This project aims to expand the current evidence for ACT interventions in this population by developing, implementing, and investigating the preliminary efficacy of a novel online-delivered ACT intervention (Empower your mind to embrace your life) for individuals with a diagnosis of young-onset PD. For this purpose, a feasibility study will be conducted to assess the acceptability and preliminary efficacy of the intervention across two groups (control and ACT intervention). This group-based intervention consists of eight weekly sessions and will be delivered in an online format (via videoconferencing). Outcome measurement will be assessed at pre-intervention, post-intervention, and at 3-month follow-up. When comparing changes in outcome variables between the control and intervention groups at post-treatment, improvements are expected only in the intervention group. These improvements are also expected to be maintained over time (at 3-month follow-up). Lastly, changes in psychological (in)flexibility processes are expected to predict changes in outcome variables in the intervention group. This study will provide important insights to research and clinical practice by providing data on the feasibility and preliminary efficacy of this novel ACT-based intervention for the context of young-onset PD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07310147
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson's Disease (PD)
Currently open trials in the same condition.
- NCT07322887 — A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreate · Phase 2 · recruiting
- NCT07348705 — Electrophysiology-based DBS Programming for PD · NA · recruiting
- NCT07316296 — Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi · Phase 3 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07310264 — Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease · Phase 1 · recruiting
Other University of Coimbra trials
Trials by the same sponsor.
- NCT07018089 — The Efficacy of the iWork.COMP Among Health Care Professionals · NA · not yet recruiting
- NCT07481253 — PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy · NA · not yet recruiting
- NCT07296081 — ⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure · recruiting
- NCT07329647 — Targeting Neurovascular Coupling in Cognitive Decline Via Nitrate-Based Supplementation · NA · recruiting
- NCT06922071 — The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07310147 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Coimbra
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07310147.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing